
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MEDP | NASDAQ | USD | Real-time | |
1MEDP | Milan | EUR | Real-time | |
01P | TradeGate | EUR | Delayed |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Name | Age | Since | Title |
---|---|---|---|
August James Troendle | 69 | 1992 | Chairman & CEO |
Robert O. Kraft | 55 | 2016 | Independent Director |
Brian T. Carley | 71 | 2016 | Independent Director |
Fred B. Davenport | 73 | 2018 | Lead Independent Director |
Cornelius Patrick McCarthy | 65 | 2018 | Independent Director |
Femida H. Gwadry-Sridhar | 63 | 2023 | Independent Director |
Dani S. Zander | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review